Qiong He

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

An Open-Label, Single-Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non-Small Cell Lung Cancer After First-Line PD-(L)1 Inhibitor.

An Open-Label, Single-Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non-Small Cell Lung Cancer After First-Line PD-(L)1 Inhibitor.

Journal: Cancer medicine

Published: February 18, 2025

Expressional and prognostic value of TREM1 in ovarian cancer: A comprehensive study based on bioinformatics and clinical analysis validation.

Expressional and prognostic value of TREM1 in ovarian cancer: A comprehensive study based on bioinformatics and clinical analysis validation.

Journal: Journal of Cancer

Published: July 19, 2024

Changing ALK-TKI mechanisms of resistance in re-biopsies of ALK-rearranged NSCLC: ALK mutations followed by SCLC-like histologic transformation: A case report.

Changing ALK-TKI mechanisms of resistance in re-biopsies of ALK-rearranged NSCLC: ALK mutations followed by SCLC-like histologic transformation: A case report.

Journal: Heliyon

Published: February 08, 2024

Circulating tumor DNA serial monitoring of relapse and responses to tislelizumab immunotherapy as second‑line monotherapy for metastatic esophageal squamous cell carcinoma: A prospective study.

Circulating tumor DNA serial monitoring of relapse and responses to tislelizumab immunotherapy as second‑line monotherapy for metastatic esophageal squamous cell carcinoma: A prospective study.

Journal: Molecular and clinical oncology

Published: June 29, 2023

Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib.

Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib.

Journal: BMC cancer

Published: February 19, 2022

cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma.

cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma.

Journal: Translational lung cancer research

Published: July 18, 2020

Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation.

Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation.

Journal: Oncogene

Published: December 14, 2019

Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer.

Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer.

Journal: Frontiers in oncology

Published: December 10, 2019

Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation.

Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation.

Journal: Oncogene

Published: July 05, 2019

Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.

Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 10, 2018

Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas.

Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 10, 2018

Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer.

Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer.

Journal: OncoTargets and therapy

Published: May 05, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026